Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma
Clinical trial NCT03139916 · COMPLETED
Trial details
- NCT number
- NCT03139916
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-13
- Primary completion
- 2022-08-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.